Skip to search.
 FTSE 100 Down 1.27%

AbbVie Inc. (ABBV)

-NYSE
61.00 Down 0.20(0.33%) 29 Apr 21:00
|After Hours: : 60.76 Down 0.24 (0.39%) 30 Apr 00:52
Prev Close:61.20
Open:61.03
Bid:60.76 x 200
Ask:61.10 x 200
1y Target Est:70.83
Beta:1.46764
Earnings Date:22 Jul - 26 Jul (Est.)
Day's Range:60.48 - 61.45
52wk Range:45.45 - 71.60
Volume:13,052,698
Avg Vol (3m):7,378,800
Market Cap:98.68b
P/E (ttm):19.49
EPS (ttm):3.13
Div & Yield:2.28 (3.73%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABBVDown 0.33%98.68b
PFEDown 0.61%202.54b
MRKDown 1.61%151.89b

Key Statistics

Forward P/E (1 yr):10.55
P/S (ttm):4.31
Ex-Dividend Date:13-Apr-16

Analysts

Annual EPS Est (Dec-16) :4.86
Quarterly EPS Est (Jun-16) :1.20
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):0.75

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA an oral therapy for the trea... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback